Ask Tes Ai

Barrett’s Esophagus and GERD

April 21, 2026Published date
April 21, 2026Last reviewed
Clinically reviewed by Physicians
Barrett’s Esophagus and GERD

Outline

Barrett's esophagus is a serious GERD complication increasing cancer risk. Learn what causes it, how it is diagnosed, and how it is monitored and treated.

Key Takeaways

  • Barrett's esophagus affects 5-15 percent of patients with GERD undergoing endoscopy, according to the ACG (2022). Barrett's esophagus is caused by chronic exposure to acid, which replaces normal esophageal cells with intestinal cells, thereby increasing the risk of cancer
  • Risk factors include long-standing GERD, male sex, age over 50, central obesity, smoking, and family history. Diagnosis requires upper endoscopy and biopsy, as Barrett's causes no distinctive symptoms
  • Dysplasia grades range from no dysplasia (0.3 percent annual cancer risk) to high-grade dysplasia (5 to 10 percent annual cancer risk). All dysplasia diagnoses require a second pathologist's confirmation
  • RFA achieves complete dysplasia eradication in approximately 90 percent of patients according to the NEJM (2009) and is the gold standard endoscopic treatment for dysplastic Barrett's esophagus
  • Long-term PPI therapy is associated with reduced dysplasia progression risk according to Gut (2014). PPI therapy combined with endoscopic surveillance is standard management for non-dysplastic Barrett's esophagus

What Causes Barrett's Esophagus?

Barrett's esophagus develops from chronic acid and bile exposure, damaging the normal esophageal lining. Repeated injury triggers a cellular transformation where normal squamous cells are replaced by more acid-resistant intestinal-type cells. While this represents an adaptive response, the transformed cells carry a significantly higher risk of malignant transformation.

Who Is at Risk?

  • Long-standing GERD symptoms lasting more than 5 years
  • Male sex: Barrett's esophagus is two to three times more common in men
  • Age over 50
  • Central obesity and smoking
  • Family history of Barrett's esophagus or esophageal adenocarcinoma
  • Presence of a hiatus hernia

What Are the Symptoms of Barrett's Esophagus?

Barrett's esophagus causes no distinctive symptoms beyond underlying GERD. Some patients paradoxically report reduced heartburn as metaplasia develops due to decreased pain sensitivity of the changed lining. The absence of distinctive symptoms means Barrett's esophagus cannot be diagnosed from symptoms alone and requires upper endoscopy with biopsy for confirmation.

How Is Barrett's Esophagus Diagnosed?

Upper Endoscopy and Biopsy

Upper endoscopy is used as the gold standard in diagnosing Barrett's esophagus. During an upper endoscopy, the gastroenterologist searches for the "salmon pink" color of Barrett's mucosa, which usually replaces the normal "pale pink" color of the esophagus. The presence of intestinal metaplasia or "goblet cells" is confirmed by biopsy.

The length of the Barrett's segment is classified as:

  • Short-segment: Less than 3 cm in length
  • Long-segment: 3 cm or more in length

Long-segment Barrett's carries a higher cancer risk than short-segment disease.

Who Should Be Screened?

According to the ACG (2022), endoscopic screening is recommended for men aged 50 or over with chronic GERD symptoms (more than 5 years) and at least two additional risk factors, including central obesity, smoking, or family history.

What Is Dysplasia in Barrett's Esophagus?

Dysplasia refers to precancerous cellular changes within Barrett's segment. Dysplasia grade directly affects the management of the patient:

  • No dysplasia: The annual cancer risk is approximately 0.3 percent
  • Low-grade dysplasia: The annual cancer risk is approximately 0.5 to 1 percent
  • High-grade dysplasia: The annual cancer risk is approximately 5 to 10 percent

A repeat evaluation by a second pathologist should be considered for all cases of dysplasia, as this carries significant clinical implications.

How Is Barrett's Esophagus Monitored and Treated?

Endoscopic Surveillance

Regular endoscopic surveillance detects dysplasia at an early treatable stage. ACG (2022) recommended surveillance intervals:

  • No dysplasia: Endoscopy every 3 to 5 years
  • Low-grade dysplasia: Endoscopy every 6 to 12 months or endoscopic eradication therapy
  • High-grade dysplasia: Endoscopic eradication therapy rather than continued surveillance

Acid Suppression Therapy

Long-term PPI therapy reduces acid exposure to the Barrett's segment and may slow dysplasia progression. According to Gut (2014), PPI use is associated with significantly reduced dysplasia and cancer progression risk in Barrett's esophagus patients.

Endoscopic Eradication Therapy

Radiofrequency Ablation (RFA)

RFA is the gold standard endoscopic treatment for dysplastic Barrett's esophagus. Controlled heat energy destroys abnormal Barrett's tissue while preserving the underlying esophageal structure. Normal squamous epithelium regenerates under continued PPI therapy. According to the NEJM (2009), RFA achieves complete dysplasia eradication in approximately 90 percent of patients.

Endoscopic Mucosal Resection (EMR)

EMR removes visible nodules or raised areas within the Barrett's segment containing early cancer or high-grade dysplasia.This is often used in conjunction with RFA for the residual flat Barrett's esophagus following nodule removal.

Conclusion

Barrett's esophagus is the most important long-term GERD complication and the primary pathway through which GERD leads to esophageal cancer. Early identification through screening, consistent PPI therapy, regular surveillance endoscopy, and timely endoscopic eradication of dysplasia are the most effective strategies for preventing esophageal adenocarcinoma.

If you have had long-standing GERD symptoms without endoscopic evaluation, discuss Barrett's esophagus screening with your gastroenterologist without delay.

Frequently Asked Questions

Can Barrett's esophagus be reversed?

Barrett’s esophagus does not spontaneously resolve but can be successfully eradicated with radiofrequency ablation. RFA results in the complete eradication of intestinal metaplasia in up to 77 percent of patients. Following eradication of intestinal metaplasia with RFA, PPI and surveillance endoscopy are mandatory because Barrett’s esophagus may recur.

Does everyone with GERD develop Barrett's esophagus?

No. Only approximately 5 to 15 percent of GERD patients undergoing endoscopy are diagnosed with Barrett's esophagus. Risk is highest in men over 50 with long-standing symptoms, central obesity, and smoking history. Most GERD patients do not progress to Barrett's esophagus with appropriate treatment and lifestyle management.

Is Barrett's esophagus painful?

Barrett's esophagus itself is not painful. Some patients paradoxically experience reduced heartburn as Barrett's develops due to decreased esophageal pain sensitivity. The absence of symptoms does not mean acid damage has stopped or that cancer risk has reduced, making regular endoscopic surveillance essential regardless of symptom status.

How often do I need an endoscopy with Barrett's esophagus?

Surveillance frequency depends on dysplasia grade. No dysplasia requires endoscopy every 3 to 5 years. Low-grade dysplasia requires endoscopy every 6 to 12 months or endoscopic treatment. High-grade dysplasia requires endoscopic eradication therapy rather than continued surveillance alone according to ACG guidelines (2022).

Can lifestyle changes reduce Barrett's esophagus cancer risk?

Weight loss, smoking cessation, and consistent PPI therapy reduce ongoing acid exposure and are associated with reduced dysplasia progression risk. However, lifestyle changes do not replace the need for endoscopic surveillance and treatment of dysplasia when present. Both medical management and endoscopic monitoring are required for comprehensive Barrett's esophagus care.

Chat with Tes to get personalized medical insights on GERD

What symptoms should I look for?
Tes
Hi! I'm here to support your health journey. Here are some symptoms you should watch for a persistent cough, shortness of breath

Disclaimer: The content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment. Always seek the advice of your physician or other qualified healthcare providers with any questions you may have regarding your symptoms and medical condition for accurate medical diagnosis. Do not delay in seeking or disregarding medical advice because of something you have read on this website. Reliance on any provided medical advice completely depends on factors like age or gender.